Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, signaling a newer revision of the page content. This change reflects an update to the page's metadata rather than to the study information.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page update changes the site revision from v3.6.3 to v3.6.4, indicating a deployment or patch.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows a revision label updated to v3.6.3, replacing the previous v3.6.0 to indicate a newer build deployment.SummaryDifference0.0%

- Check66 days agoChange DetectedRecruitment status is updated to not recruiting, reflecting that participants are no longer being sought. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a header formatting change for Intervention/Treatment were added, along with a version update to v3.6.0.SummaryDifference0.2%

- Check74 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, signaling a new release of the page content for the LIBRETTO-001 study listing.SummaryDifference0.0%

- Check95 days agoChange DetectedThe website revision tag was updated from v3.5.3 to v3.5.4, indicating a small deployment update to the page’s framework. It does not imply changes to the study information shown on the page.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.